secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immuneering Corp (IMRX)
CIK:        0001790340
Form:       8-K
Filed at:   2022-07-25T23:59:59+00:00
Accession:  0001104659-22-082207
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Immuneering CFO Biren Amin departs; VP Finance Mallory Morales named new CFO
----------------------------------------------------------------------------

- Biren Amin steps down as CFO effective Aug 10, 2022; departure not due to disagreement.
- Mallory Morales appointed principal financial officer, accounting officer, and treasurer effective Aug 10.
- Morales receives $30,000 cash bonus (two $15k installments) and option for 10,000 shares.
- Morales previously VP Finance since May 2021; prior roles at Gilead, Immunomedics, L'Oréal; CPA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1790340/000110465922082207/0001104659-22-082207-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1790340/000110465922082207/tm2221718d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-082207

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer